Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
TDG Gold Announces Acquisition Of Anyox Copper And C$25 Million Bought Deal Private Placement
June 17 (Reuters) - TDG Gold Corp TDG.V:TDG GOLD ANNOUNCES ACQUISITION OF ANYOX COPPER AND C$25 MILLION BOUGHT DEAL PRIVATE PLACEMENTTDG GOLD CORP - TO BUY ALL SECURITIES OF ANYOXTDG GOLD CORP - ANYOX SHAREHOLDERS TO HOLD 20% OF TDG POST-DEAL
Reuters
Tue, Jun 17
Kirkland's To Consolidate To About 290 Store Locations
June 17 (Reuters) - Kirkland's Inc KIRK.O:KIRKLAND'S INC - COMPANY TO CONSOLIDATE TO ABOUT 290 STORE LOCATIONSKIRKLAND'S INC - TO REBRAND AS THE BRAND HOUSE COLLECTIVEKIRKLAND'S INC - TICKER SYMBOL TO CHANGE FROM 'KIRK' TO 'TBHC'
Reuters
Tue, Jun 17
Beneficient Announces Court Approval Of GWG Litigation Settlement
June 17 (Reuters) - Beneficient BENF.O:BENEFICIENT ANNOUNCES COURT APPROVAL OF GWG LITIGATION SETTLEMENTBENEFICIENT - BANKRUPTCY COURT APPROVES BENEFICIENT SETTLEMENT AGREEMENT IN GWG LITIGATION
Reuters
Tue, Jun 17
Vireo Growth Provides Corporate Update Post Closing Of All Merger Transactions
June 17 (Reuters) - Vireo Growth Inc VREO.CD:VIREO GROWTH INC. PROVIDES CORPORATE UPDATE POST CLOSING OF ALL MERGER TRANSACTIONSVIREO GROWTH INC - EXPECTS Q2 2025 PRO-FORMA REVENUE OF $88-$91 MILLION, ADJUSTED EBITDA OF $23-$24 MILLIONVIREO GROWTH INC - EXPECTS IMPROVED PROFITABILITY TO SECURE BETTE...
Reuters
Tue, Jun 17
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application For The Treatment Of Dry Eye Disease
June 17 (Reuters) - Aldeyra Therapeutics Inc ALDX.O:ALDEYRA THERAPEUTICS RESUBMITS REPROXALAP NEW DRUG APPLICATION FOR THE TREATMENT OF DRY EYE DISEASEALDEYRA THERAPEUTICS INC - NO SAFETY CONCERNS IDENTIFIED IN CLINICAL TRIAL
Reuters
Tue, Jun 17
Israel has Iran's military leadership on the run, military official says
JERUSALEM, June 17 (Reuters) - Israel struck dozens of targets linked to Iran's nuclear and ballistic missile programmes overnight and has got Iran's military leadership "on the run", an Israeli military official said on Tuesday.The official, speaking on condition of anonymity, confi...
Reuters
Tue, Jun 17
Unicycive Therapeutics Announces Reverse Stock Split
June 17 (Reuters) - Unicycive Therapeutics Inc UNCY.O:UNICYCIVE THERAPEUTICS, INC. ANNOUNCES REVERSE STOCK SPLITUNICYCIVE THERAPEUTICS INC - TO IMPLEMENT 1-FOR-10 REVERSE STOCK SPLITUNICYCIVE THERAPEUTICS INC - COMMON STOCK TO TRADE ON SPLIT-ADJUSTED BASIS FROM JUNE 20UNICYCIVE THERAPEUTICS INC - RE...
Reuters
Tue, Jun 17
Koryx Copper Provides Project Development Update For The Haib Copper Project, Southern Namibia
June 17 (Reuters) - Koryx Copper Inc KRY.V:KORYX COPPER PROVIDES PROJECT DEVELOPMENT UPDATE FOR THE HAIB COPPER PROJECT, SOUTHERN NAMIBIAKORYX COPPER INC - TO PUBLISH PEA FOR HAIB COPPER PROJECT IN Q3 2025KORYX COPPER INC - COMMENCES COLUMN LEACH TESTS, RESULTS EXPECTED EARLY 2026
Reuters
Tue, Jun 17
Purple Biotech Announces Initiation Of Phase 2 Study Of Nt219 In Patients With Head And Neck Cancer
June 17 (Reuters) - Purple Biotech Ltd PPBT.TA:PURPLE BIOTECH ANNOUNCES INITIATION OF PHASE 2 STUDY OF NT219 IN PATIENTS WITH HEAD AND NECK CANCERPURPLE BIOTECH LTD - STUDY TO BEGIN WITH 10 PATIENTS PER ARM, EXPAND TO 29
Reuters
Tue, Jun 17
Ventyx Biosciences Announces Positive Data From Its Phase 2A Trial Evaluating Vtx3232 In Patients With Early-Stage Parkinson’S Disease
June 17 (Reuters) - Ventyx Biosciences Inc VTYX.O:VENTYX BIOSCIENCES ANNOUNCES POSITIVE TOP-LINE DATA FROM ITS PHASE 2A SAFETY AND BIOMARKER TRIAL EVALUATING VTX3232 IN PATIENTS WITH EARLY-STAGE PARKINSON’S DISEASEVENTYX BIOSCIENCES INC - VTX3232 STUDY MEETS PRIMARY GOAL OF SAFETY AND TOLERABILITYVE...
Reuters
Tue, Jun 17
Oncocyte Changes Name To Insight Molecular Diagnostics
June 17 (Reuters) - OncoCyte Corp OCX.O:ONCOCYTE CHANGES NAME TO INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX), MOVES HEADQUARTERS TO NASHVILLE
Reuters
Tue, Jun 17
Mineralys Therapeutics Announces Positive Topline Results From Phase 2 Trial Of Lorundrostat For The Treatment Of Hypertension
June 17 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2 EXPLORE-CKD TRIAL OF LORUNDROSTAT FOR THE TREATMENT OF HYPERTENSION IN SUBJECTS WITH CKD AND ALBUMINURIAMINERALYS THERAPEUTICS INC - LORUNDROSTAT DEMONSTRATES FAVORABLE SAFETY...
Reuters
Tue, Jun 17
US Transport Secretary wants civil aviation to return to zero tariffs
PARIS, June 17 (Reuters) - U.S. Transport Secretary Sean Duffy said on Tuesday that he wanted civil aviation to return to a 1979 zero-tariff trade agreement.Speaking at the Paris Airshow, Duffy said the White House was aware that the U.S. is a net exporter in aerospace, but added that it was dealing...
Reuters
Tue, Jun 17
Srq Resources Start Drilling At Target 900, Lac Brulé Property
June 17 (Reuters) - SRQ Resources Inc SRQ.V:SRQ RESOURCES START DRILLING AT TARGET 900, LAC BRULÉ PROPERTY
Reuters
Tue, Jun 17
KFC parent Yum Brands names insider Chris Turner as CEO
June 17 (Reuters) - Yum Brands YUM.N on Tuesday named its chief financial officer Chris Turner as its chief executive officer, replacing company veteran David Gibbs.
Reuters
Tue, Jun 17
Sword Health valued at $4 billion in latest funding round
June 17 (Reuters) - Sword Health raised $40 million in a funding round led by General Catalyst, the company said on Tuesday, valuing it at $4 billion.
Reuters
Tue, Jun 17
ADVISORY-Alert incorrectly tagged to Ascend Wellness Holdings withdrawn
An alert on Ascend Performance Materials winding down one of its production facilities was incorrectly tagged to U.S.-based multi-state cannabis operator Ascend Wellness Holdings AAWH.PK, an unrelated entity, and has been withdrawn. There will be no substitutes.STORY_NUMBER:nFWN3SK0N2STORY_DATE:17/0...
Reuters
Tue, Jun 17
Lilly To Acquire Verve Therapeutics To Advance One-Time Treatments For People With High Cardiovascular Risk
June 17 (Reuters) - Verve Therapeutics Inc VERV.O:LILLY TO ACQUIRE VERVE THERAPEUTICS TO ADVANCE ONE-TIME TREATMENTS FOR PEOPLE WITH HIGH CARDIOVASCULAR RISKELI LILLY - PROPOSED DEAL FOR PURCHASE PRICE OF $10.50 PER SHARE IN CASHELI LILLY - PROPOSED DEAL FOR A TOTAL POTENTIAL CONSIDERATION OF UP TO ...
Reuters
Tue, Jun 17
RPM Announces Strategic Acquisition Of Ready Seal
June 17 (Reuters) - RPM International Inc RPM.N:RPM ANNOUNCES STRATEGIC ACQUISITION OF READY SEAL INC.RPM INTERNATIONAL INC - TERMS OF RPM-READY SEAL DEAL NOT DISCLOSED
Reuters
Tue, Jun 17
W&T Announces Settlement Agreement With Majority Of Surety Providers
June 17 (Reuters) - W&T Offshore Inc WTI.N:W&T ANNOUNCES SETTLEMENT AGREEMENT WITH MAJORITY OF SURETY PROVIDERSW&T OFFSHORE INC - SURETY PROVIDERS TO WITHDRAW COLLATERAL DEMANDS, NO INCREASE IN PREMIUMS THROUGH 2026
Reuters
Tue, Jun 17
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free